With the surging cases of coronavirus in India, the major challenge is faced by the hospitals to offer critical care to every patient. Ventilators are key medical equipment required for the treatment of COVID-19 patients, as they have a major issue in breathing. Ventilators support breathing to the patients by delivering oxygen into the lungs and eliminate CO2 from the body. Like other countries, Indian companies shore up their efforts to increase ventilator production in the country. However, the shortage of components, including sensors, controllers, and chips has created a production challenge for ventilators in the country. 

Due to the ban on international flight amid COVID-19, the conditions have worsened as the ventilator manufacturers are struggling to lift components from the US, Chinese, and Japanese suppliers. AgVa Healthcare said that the ban on the international flight has affected the supply of components from China. At Shenzhen China, electronic components are ready, however, they are not able to ship to AgVa Healthcare due to the flight ban. India is among the major importers of electronic components. Due to the lack of a stable policy and high cost, there is a lack of efforts to establish local semiconductor facilities over the years. Therefore, the medical device manufacturers rely heavily on foreign companies for the supply of electronic components. 

However, the ventilator manufacturers have been finding out solutions regarding the supply of components. For instance, Skanray Technologies Pvt Ltd. plans to work with Bharat Electronics to support in sharing components. In addition, it is working with the Defense Research and Development Organization (DRDO) to meet the emergency requirement. The DRDO is expected to work with automobile manufacturers, including Tata Motors and Mahindra & Mahindra Ltd. for the fabrication of ventilator components. 

It has identified nine local companies to transfer design for the production of components. The government has already in communication with five automobile companies, including Mahindra and Mahindra (M&M), Tata Motors, Maruti Suzuki, Hyundai Motor, and Honda Cars, to explore the possibility of manufacturing ventilators at their plants. Indian Health Ministry has reportedly demanded a public sector unit (PSU) regarding the production of 10,000 ventilators and Bharat Heavy Electrical Electricals Ltd. (BHEL) would supply 30,000 by June 2020. 

The study on the effect of COVID-19 on India ventilator industry is segmented into portable and intensive care ventilators. There is an increased production of ventilators in India amid COVID-19 effect. For instance, India’s largest prototyping center in Telangana, T Works has increased its focus on the designing and development of a low-cost portable ventilator along with the hardware community in Hyderabad amid COVID-19 pandemic. Moreover, Kanpur based Indian Institute of Technology (IIT) is engaged in the development of a low-cost portable alternative to ventilators available in the market. It is expected that this ventilator will be available at nearly $900 per unit as the institute is outsourcing all the components from India only.  

Key manufacturers focusing on the production of ventilators to treat patients with COVID-19 include Bharat Heavy Electricals Ltd. (BHEL), Skanray Technologies Pvt Ltd., Biodesign Innovation Labs, and A.B. Industries (Max Ventilator). Skanray Technologies Pvt Ltd. is focusing on ramping up production capabilities and locally assemble nearly 100,000 ventilators in India. It is working with DRDO that can support to cope up with the increasing demand for ventilators in the country. Further, Indian startup Biodesign Innovation Labs has developed a portable ventilator or automated respiratory assist device, RespirAid, which is used to make stable the patient condition during a respiratory arrest. As per the company, it can support to reduce morbidity resulted due to ventilators shortage in low-resource settings. The company needs nearly $1.3 million for the establishment of a large-scale production facility to produce and distribute RespirAid to support patients with coronavirus epidemics.

Research Methodology

OMR global recently published a report addressing the impact of COVID-19 on India ventilator industry. The study is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, laws and policies, consumer behavior and macro-economic factors. Besides, an expected recovery timeline of the industry will also be included with the best- and worst-case scenario which will aid clients to take their future steps in the decision-making process.

Sources Include

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog
• Government Organizations Reports

The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

The Report Covers

• Comprehensive research methodology of the pre and post-COVID-19 impact on India ventilator industry.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting India ventilator industry.
• Insights about market determinants which are India ventilator industry.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.